HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiuliang Zhao Selected Research

R333

12/2020JAK Inhibitors: Prospects in Connective Tissue Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiuliang Zhao Research Topics

Disease

16Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 01/2014
11Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 04/2016
9Thrombocytopenia (Thrombopenia)
06/2022 - 07/2015
7Pulmonary Arterial Hypertension
11/2022 - 01/2014
6Thrombosis (Thrombus)
01/2022 - 04/2016
5Interstitial Lung Diseases (Interstitial Lung Disease)
12/2021 - 03/2016
4Autoimmune Diseases (Autoimmune Disease)
11/2022 - 01/2018
4Arthritis (Polyarthritis)
10/2021 - 07/2015
3Systemic Scleroderma (Systemic Sclerosis)
12/2021 - 12/2020
3Takayasu Arteritis (Arteritis, Takayasu's)
12/2020 - 12/2016
3Exanthema (Rash)
10/2019 - 03/2016
2Connective Tissue Diseases (Connective Tissue Disease)
11/2022 - 12/2020
2Rheumatoid Arthritis
01/2022 - 12/2020
2Myositis (Idiopathic Inflammatory Myopathies)
11/2021 - 11/2020
2Pulmonary Hypertension
11/2021 - 10/2018
2Fibrosis (Cirrhosis)
11/2021 - 01/2020
2Infections
01/2021 - 03/2017
2Proteinuria
01/2021 - 12/2020
2Opportunistic Infections (Opportunistic Infection)
01/2021 - 12/2020
2Inflammation (Inflammations)
12/2020 - 03/2017
2Dermatomyositis (Dermatopolymyositis)
12/2020 - 11/2020
2Hyperglycemia
01/2018 - 07/2017
1Lymphopenia (Lymphocytopenia)
06/2022
1Retinal Vein Occlusion
02/2022
1Retinal Artery Occlusion
02/2022
1Transverse Myelitis (Necrotizing Myelitis)
02/2022
1Heart Valve Diseases (Valvular Heart Disease)
02/2022
1Myelitis
02/2022
1Thrombotic Microangiopathies
02/2022
1Ankylosing Spondylitis
01/2022
1COVID-19
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Renal Artery Obstruction (Renal Artery Stenosis)
01/2022
1Psoriatic Arthritis
01/2022
1Hypoxia (Hypoxemia)
12/2021
1Cicatrix (Scar)
11/2021
1Alopecia (Baldness)
11/2021
1Left Ventricular Dysfunction
11/2021
1Necrosis
08/2021
1Hemorrhage
01/2021
1Stroke (Strokes)
01/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Cryoglobulinemia
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
05/2022 - 07/2015
8Antiphospholipid AntibodiesIBA
11/2022 - 02/2017
7Immunoglobulin G (IgG)IBA
05/2022 - 04/2016
6Biomarkers (Surrogate Marker)IBA
12/2021 - 04/2017
5C-Reactive ProteinIBA
11/2021 - 11/2015
4Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 12/2020
4Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2015
4AutoantibodiesIBA
05/2022 - 01/2014
4Immunoglobulin A (IgA)IBA
01/2022 - 04/2017
4Phospholipids (Phosphatides)FDA LinkGeneric
08/2021 - 07/2015
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2022 - 11/2021
3Immunoglobulin M (IgM)IBA
05/2022 - 04/2017
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 12/2020
3CytokinesIBA
01/2021 - 12/2020
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
11/2022 - 12/2020
2Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2020
2Uric Acid (Urate)IBA
11/2021 - 03/2016
2Biological ProductsIBA
01/2021 - 01/2021
2tofacitinibIBA
12/2020 - 10/2019
2EnzymesIBA
11/2020 - 03/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2020 - 07/2017
2Rheumatoid FactorIBA
01/2020 - 05/2018
27-(N-(3-aminopropyl)amino)heptan-2-oneIBA
11/2019 - 03/2016
2RibonucleoproteinsIBA
05/2019 - 07/2017
2GlucocorticoidsIBA
01/2018 - 07/2017
2Prothrombin (Factor II)IBA
01/2018 - 04/2017
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2022
1Complement System Proteins (Complement)IBA
02/2022
1Retinaldehyde (Retinal)IBA
02/2022
1N-phthaloylglutamic acidIBA
01/2022
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022
1HLA-A Antigens (HLA-A)IBA
01/2022
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022
1Interleukin-7 (Interleukin 7)IBA
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2022
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
01/2022
1pristane (pristan)IBA
12/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Indicators and Reagents (Reagents)IBA
11/2021
1CollagenIBA
11/2021
1Triglycerides (Triacylglycerol)IBA
11/2021
1AutoantigensIBA
01/2021
1CreatinineIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020
1Interleukin-6 (Interleukin 6)IBA
12/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2020
1ruxolitinibIBA
12/2020
1Rituximab (Mabthera)FDA Link
12/2020
1Complement C3 (C3 Complement)IBA
12/2020
1peficitinibIBA
12/2020
1upadacitinibIBA
12/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2020
1thiamine triphosphorate (TTP)IBA
12/2020

Therapy/Procedure

4Therapeutics
02/2022 - 03/2017